CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
CHA Responds to 2 CMS Rules Impacting Access to Care for Children
Medicaid MCO Provider Tax Final Rule Summary
Protect and Preserve 340B for Children’s Hospitals
CHA Responds to 2 CMS Rules Impacting Access to Care for Children
CHA responded to two proposed rules on Medicaid funding and Hospital Conditions of Participation.
Feb. 18, 2026
Medicaid MCO Provider Tax Final Rule Summary
This summary outlines the key provisions relevant to children’s hospitals within the Medicaid managed care organization (MCO) provider tax final rule.
Feb. 17, 2026
Protect and Preserve 340B for Children’s Hospitals
The 340B program ensures access to care for children.
Feb. 12, 2026
